Emerging patent issues in genomic diagnostics

被引：17

作者：

Barton, John H.

机构：

[1] Stanford Law Sch, Stanford, CA 94305 USA

[2] NIH, Dept Clin Bioeth, Bethesda, MD USA

来源：

NATURE BIOTECHNOLOGY | 2006年 / 24卷 / 08期

关键词：

DRUG DEVELOPMENT; PHARMACOGENETICS; CANCER;

D O I：

10.1038/nbt0806-939

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：939 / 941

页数：3

共 26 条

[1]

ALLEN RH, 1990, Patent No. 4940658

[2]

[Anonymous], 2002, ETH PAT DNA DISC PAP

[3] Pharmacogenomics in drug development: societal and technical aspects [J].

Bartfai, T .

PHARMACOGENOMICS JOURNAL, 2004, 4 (04) :226-232

[4] Effects of patents and licenses on the provision of clinical genetic testing services [J].

Cho, MK ;

Illangasekare, S ;

Weaver, MA ;

Leonard, DGB ;

Merz, JF .

JOURNAL OF MOLECULAR DIAGNOSTICS, 2003, 5 (01) :3-8

[5]

COHEN RL, 2003, Patent No. 6573043

[6] Biotech patents: looking backward while moving forward [J].

Eisenberg, RS .

NATURE BIOTECHNOLOGY, 2006, 24 (03) :317-319

[7]

FILMORE D, 2004, MOD DRUG DISCOV, V7, P47

[8]

GORMAB EG, 2001, IVD TECHNOL, V7, P59

[9]

GREBOW M, 2005, IVD TECHNOL, V11, P14

[10] Can patents deter innovation? The anticommons in biomedical research [J].

Heller, MA ;

Eisenberg, RS .

SCIENCE, 1998, 280 (5364) :698-701

← 1 2 3 →